Transcutaneous Neuromodulation improved inflammation and sympathovagal ratio in patients with primary biliary ssscholangitis and inadequate response to Ursodeoxycholic acid: a pilot study

BACKGROUND: At present, ursodeoxycholic acid (UDCA) is internationally recognized as a therapeutic drug in clinic. However, about 40% Primary Biliary Cholangitis (PBC) patients are poor responders to UDCA. It has been demonstrated that Transcutaneous Neuromodulation (TN) can be involved in gut motil...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hui, Yang, Hang, Wang, Lixia, Shi, Honggang, Liu, Bojia, Lin, Xue, Chang, Qingyong, Chen, Jiande D. Z., Duan, Zhijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395375/
https://www.ncbi.nlm.nih.gov/pubmed/32738911
http://dx.doi.org/10.1186/s12906-020-03036-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395375/
https://www.ncbi.nlm.nih.gov/pubmed/32738911
http://dx.doi.org/10.1186/s12906-020-03036-w

Ejemplares similares